drugset / Trial / NCT00152542
Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Our previous data demonstrated that premature infants treated with inhaled nitric oxide at birth had improved neurodevelopmental outcomes at two years corrected age. We now wish to determine whether this benefit continues through school age.
Timeline
- Start
- 2005-05
- Primary completion
- 2006-09
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitric Oxide | Other / unclassified | 5 ppm | Inhaled |